Devonian Health Group Moves Forward with Share Consolidation Ahead of U.S. Listing Devonian Health Group introduces a reverse stock split in preparation for a possible U.S. stock exchange listing, enhancing its market presence.

Devonian Health Group Moves Forward with Share Consolidation Ahead of U.S. Listing #U.S._Listing #Devonian_Health_Group #stock_consolidation

Devonian Health Group Shares Significant Findings on Thykamine as Innovative Anti-Inflammatory Solution Devonian Health Group revealed groundbreaking findings on Thykamine™ in a recent study, highlighting its effectiveness as a new anti-inflammatory agent. This innovation holds promise for managing chronic inflammatory diseases.

Devonian Health Group Shares Significant Findings on Thykamine as Innovative Anti-Inflammatory Solution #Canada #Quebec #Devonian_Health_Group #Thykamine #Anti-Inflammatory

Devonian Health Group Set to Present at ThinkEquity Conference in New York Devonian Health Group will participate in the upcoming ThinkEquity Conference in NYC, showcasing its advancements in inflammatory disease treatments.

Devonian Health Group Set to Present at ThinkEquity Conference in New York #Canada #Quebec #inflammatory_diseases #Devonian_Health_Group #ThinkEquity_Conference